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Background: Irreversible electroporation (IRE) is a novel, non-thermal method of tissue ablation using
short pulses of high-voltage DC current to ablate tissue.
Methods: Irreversible electroporation of the pancreas was performed in four domestic female swine
using two monopolar probes spaced 9–15 mm apart. Ninety pulses of 1500 V/cm were delivered for each
ablation.
Results: All animals survived for their designated times of 2 h (n = 1), 2 days (n = 1) and 14 days (n = 2),
respectively. No procedure-related complications occurred. Three animals in which probes had been
spaced at intervals of 10  1 mm showed evidence of irreversible ablation, with ablation height ranging
from <10 mm to 21 mm and ablation width ranging from <10 mm to 16 mm by gross appearance and
triphenyltetrazolium chloride (TTC) staining. The only animal in which probes had been spaced at intervals
of 15 mm did not show evidence of irreversible ablation at 2 weeks. This may be secondary to the wider
probe spacing and relatively low voltage, which results in a mostly reversible form of electroporation
without cell death.
Conclusions: Irreversible electroporation appears to be a safe method for pancreas tissue ablation.
Staining with TTC can predict the zone of IRE ablation within 2 h of treatment.
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Introduction
Irreversible electroporation (IRE) is a novel ablation technology
that utilizes short pulses of high-voltage electrical energy for tissue
ablation. It is performed by placing electrodes into the tissue and
delivering 90 pulses of 1000–3000 V/cm DC energy between the
electrodes. Cell death is initiated via the creation of micropores in
the cell membrane.1
Irreversible electroporation is a non-thermal form of ablation.
Previous preclinical studies in swine liver demonstrated the ability
of IRE to ablate tissue immediately adjacent to hepatic veins
without evidence of heat sink. Hepatic arteries, portal veins and
bile ducts within the ablation zone appear more resistant to the
effects of IRE.1–3
The aim of the current study was to evaluate the feasibility and
safety of performing IRE ablations in vivo in the pancreas in
a swine model. Additionally, the ability of triphenyltetrazolium
chloride (TTC) staining to predict the zone of IRE ablation was
evaluated.
Materials and methods
This study was approved by our institution’s Animal Care and
Use Committee.
General anaesthesia was induced in four domestic female swine
using glycopyrrolate 0.003 mg/kg i.m., telazol 5 mg/kg i.m. and
xylazine 2 mg/kg i.m., and sodium thiopental 20 mg/kg i.v. as
needed. Animals were intubated to facilitate mechanical ventila-
tion. General anaesthesia was maintained with 2–4% isoflurane in
oxygen. Pre-emptive analgesia was administered using buprenor-
phine 0.03 mg/kg i.m. The adequacy of anaesthesia was deter-
mined according to jaw tone and pedal reflex. Anaesthesia was
increased if any response to stimuli was noted. A baseline evoked
motor response was obtained with a nerve stimulator positioned
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near the ulnar nerve. Animals were monitored intraoperatively
using telemetry and pulse-oximetry.
The abdominal wall was aseptically prepared using betadine
scrub and solution. Prior to incision, animals received a single
dose of cephazolin 40 mg/kg i.v. A 12-cm incision was made in
the midline of the abdomen and the peritoneal cavity entered.
Pancuronium 0.1 mg/kg was administered to achieve reversible
paralysis as monitored by evoked motor response.
The segment of pancreas abutting the superior mesenteric vein
and duodenum was identified and two monopolar IRE electrodes
were positioned within the pancreatic parenchyma, 10–15 mm
apart. The active portion of the electrodes was exposed for a
length of 20 mm. Electrode positioning was confirmed by intra-
operative ultrasound. Pulses of 1500 V/cm were delivered between
the electrodes in 100-microsecond (ms) pulses as determined
by the manufacturer’s treatment software (NanoKnife®; Angio
Dynamics, Inc., Queensbury, NY, USA). Ninety pulses were deliv-
ered per ablation. The pulses were delivered in groups of 10 with
a 250-ms pause between pulses.
Muscle relaxation was reversed using neostigmine 0.044–
0.066 mg/kg i.v. and atropine 0.005 mg/kg i.v. Animals were
recovered. Postoperative pain control was achieved using Fentanyl
transdermal patches 75 mcg/h and tramadol 150 mg administered
by mouth twice daily for 3 days and as needed.
Phlebotomy for amylase, lipase, AST (aspartate aminotrans-
ferase), ALT (alanine aminotransferase) and bilirubin was per-
formed pre-procedure while the animals were under anaesthesia
and on postoperative days 2 and 5 in surviving animals.
Once the target survival times of 2 h (n = 1), 2 days (n = 1) and
14 days (n = 2) had been reached, animals were anaesthetized
as previously described and euthanized with pentobarbital
100 mg/kg. Laparotomy was performed and the pancreas was
recovered. The area of ablation within the pancreas was sectioned
at 5-mm intervals for gross evaluation. The 5-mm section in the
centre of the ablation cavity was stained with TTC. The remaining
sections were fixed in formalin. The height and width of ablation
zones were measured. Histological analysis was performed follow-
ing haematoxylin and eosin (H+E) staining.
Results
All four swine survived to the designated times and no complica-
tions were encountered. Treatment parameters and ablation sizes
are shown in Table 1. In all animals, the electrodes were placed
with the assistance of a 10-mm spacer. Although the electrodes all
entered the pancreatic tissue at spacing of exactly 10 mm, the
final locations of the active portion of the electrode tips varied
slightly as documented by intraoperative ultrasound. The distance
between the electrode tips ranged from 9 mm to 15 mm (Table 1).
Immediately following IRE, the ablated pancreatic tissue
showed gross evidence of oedema and haemorrhage (Fig. 1).
At 2 h there was histological evidence of haemorrhagic necro-
sis. Staining with TTC showed a clear demarcation between viable
tissue, which retained the TTC stain, and non-viable tissue, which
did not retain the TTC stain.
At 48 h the zone of ablation remained well demarcated by
gross evidence, H+E staining and TTC staining. The blood vessels
and the pancreatic ducts appear to be more resistant to the effects
of IRE (Fig. 2).
At 2 weeks, the animal in which the electrodes had been spaced
10 mm apart showed evidence of fibrosis within the ablation zone
(Fig. 3). No histological changes were identified at 2 weeks in the
animal in which the electrode tips had been spaced 15 mm apart.
Serum amylase and lipase were measured in the surviving
animals at baseline (2380 [standard deviation, SD 620] and 5.8
[SD 5.7], respectively), at postoperative day 2 (2802 [SD 111] and
32 [SD 17], respectively) and at postoperative day 5 (2420 [SD
511] and 101 [SD 58], respectively). There was no clinical evi-
dence of pancreatitis in any of the animals. All the animals exhib-
ited minimal pain by demonstrating normal activity and normal
feeding habits.
Discussion
Irreversible electroporation refers to the delivery of short pulses of
high-voltage electrical energy to the target tissue, which results in
micropore formation in the lipid bilayer of cells and subsequent
cell death. Electroporation has also been used in a reversible
manner to improve the delivery of bleomycin in the treatment
of squamous cell carcinoma of the head and neck.4–8 Rubinsky
et al. demonstrated the ability of IRE to kill hepatocytes in swine
liver with preservation of the portal structures. They also demon-
strated hepatocyte necrosis immediately adjacent to large veins
within the ablation zone, which were unaffected by the heat sink
effect normally seen with thermal ablation techniques.1
Table 1 Irreversible electroporation ablations created with two monopolar probes and 90 pulses of 1500 V/cm in vivo in swine pancreas
Location n Exposurea Distanceb Survival Ablation zonec
Pancreas 1 20 mm 10 mm 2 h 15 ¥ 16 mm
Pancreas 1 20 mm 9 mm 2 days 21 ¥ 12 mm
Pancreas 1 20 mm 10 mm 2 weeks <10 ¥ <10 mm
Pancreas 1 20 mm 15 mm 2 weeks Not visualized
aExposure refers to the length of the electrode that is active during the delivery of treatment
bDistance between monopolar electrodes
cThe width and height of ablation zones were measured following triphenyltetrazolium chloride staining and fixation
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Lee et al. corroborated the findings of Rubinsky’s group and
demonstrated the ability to deliver the IRE treatment percutane-
ously in swine liver.2
Miller et al. reported the ability of IRE to ablate human hepa-
tocarcinoma cells in vitro. They showed that multiple pulses
appeared to be more effective in cancer cell ablation than the
delivery of equivalent energy in a single pulse.9
Al-Sekere et al. reported complete regression using IRE in 12 of
13 cutaneous tumours implanted in mice. Their work confirmed
Figure 1 Gross intraoperative photographs of one swine pancreas
(A) immediately before irreversible electroporation (IRE) showing
normal pancreas, and (B) immediately after IRE, showing an area of
oedema and haemorrhage corresponding to the area of ablation
Figure 2 Pancreatic tissue at 2 days after irreversible electroporation
(IRE). (A) Fixed tissue after triphenyltetrazolium chloride (TTC) stain-
ing. The red dye is retained by viable cells. Areas devoid of red dye
represent regions of cell necrosis. (B) Pancreatic tissue at 20¥
original magnification after haematoxylin and eosin (H+E) staining.
Pancreatic acinar tissue is destroyed with relative preservation of
the blood vessels and pancreatic ducts. (C) Pancreatic tissue at
10¥ original magnification after H+E staining, demonstrating preser-
vation of the pancreatic duct within the zone of IRE ablation
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improved results with cancer cell death using multiple short
pulses of electrical energy.10
Our group has previously reported the safety and efficacy of
performing IRE ablations in the liver hilum with preservation of
the portal vein, bile duct and hepatic artery within the ablation
zone. In addition, we reported the ability of TTC staining to
accurately predict the zone of IRE ablation as early as 15 min
following ablation in liver.3
Irreversible electroporation requires the insertion of electrodes
into the target tissue for the delivery of the treatment. As with
other forms of ablation (e.g. microwave and radiofrequency
ablation), bleeding can occur at the electrode puncture site.
The high-voltage current needed for ablation is unique to IRE.
This necessitates reversible chemical paralysis to prevent muscle
contraction. Although cardiac arrhythmias have been reported,
the risk of arrhythmia can be minimized with cardiac synchroni-
zation. No IRE complications were encountered in our study.
The current paper reports a pilot study demonstrating the
safety of IRE in swine pancreas. All of the animals survived to the
designated time without clinical or laboratory evidence of pan-
creatitis. We believe the lack of pancreatitis can be explained in
several ways. Firstly, the area of tissue ablated is relatively small
and focal. Secondly, the pancreatic duct appears to be more resis-
tant to the effects of IRE. Finally, the time-points selected for
phlebotomy were not ideal for identification of mild pancreatitis.
Future studies should include phlebotomy at earlier time-points
in order to detect any subclinical pancreatitis.
Triphenyltetrazolium chloride staining is able to predict the
zone of IRE ablation in the pancreas as early as 2 h after therapy.
Histological correlation confirmed cell death in pancreatic
tissue following IRE in three of the four animals in our study.
The fourth animal was the only subject in which the monopolar
electrodes were more widely spaced, at 15 mm vs. 10 mm. We
believe that the lack of histological changes at 2 weeks in
this animal may be explained by technical issues relating to
the relatively wide spacing of the electrodes and the use of a
relatively low voltage (1500 V/cm), which resulted in a mostly
reversible form of electroporation without cell death. Local
tissue repair cannot be entirely excluded as a contributing cause
of these findings.
In summary, IRE appears to be safe and effective for the abla-
tion of pancreatic tissue. Staining by TTC is able to predict the
zone of IRE ablation in the pancreas as early as 2 h following
treatment. Further studies are needed to determine the optimal
electrode spacing and voltage for creating IRE ablations in the
pancreas. Additional studies will be needed to determine the
efficacy of IRE for the ablation of pancreatic tumours.
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Figure 3 Pancreatic tissue at 2 weeks after irreversible electropora-
tion shown at 4¥ original magnification reveals scarring in the abla-
tion zone with preservation of the pancreatic ducts
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